
Corporate Notices: Titan Biotech Opens Demat Window; Shivalik Bank Announces Auction Schedule
Several companies have issued formal notices regarding shareholder facilities, property possessions, and scheduled auctions, detailing operational updates and financial obligations for investors and borrowers.Titan Biotech Ltd: Special Dematerialisation Window for Physical Shares
Titan Biotech Limited has informed shareholders about a Special Window for the re-lodgement of transfer requests and the dematerialisation of physical shares. This window is open for a period of one year, running from February 5, 2026, to February 4, 2027.The company confirmed that these details were published in newspaper advertisements in Financial Express (English) and Naya India (Hindi) on May 6, 2026.
Investor Facility Updates
CGMP PHARMA N:A notice was issued to facilitate investors and safeguard their rights in securities. This opportunity is specifically for the dematerialisation ("demat") of physical securities that were purchased prior to April 1, 2019. The notice clarified that investors who were unable to meet the earlier deadline of January 2020 can utilize this facility by transmitting the requisite documents to the Company’s Registrar and Transfer Agent, BEETAL Financial & Compute Services Put Ltd.
Titan Biotech Limited:
Regarding the physical shares, a notice was issued confirming that the window is open for dematerialisation of physical securities that were purchased prior to April 1, 2019.
Auction Notice: Shivalik Small Finance Bank Ltd.
Shivalik Small Finance Bank Ltd. released an auction notice detailing accounts scheduled for auction. The auction date is set for May 15, 2026, at 11:00 am. The notice lists multiple branches, account numbers, and the associated borrowers.The details of the scheduled auctions are provided below:
| Branch | Account Number | Borrower Name |
|---|---|---|
| SARSAWA HAPUR | 101242511112 701242010901 | BRAJESH KUMAR RANIB |
| SARSAWA HAPUR | 102542510579 | AS MOHAMMAD |
| SARSAWA HAPUR | 102542510578 | AS MOHAMMAD |
| KHATAULI MAWANA | 102042510325 | JABIR RATHAUR |
| MAWANA | 102842510319 | GOURAV CHAODHARI |
| MAWANA | 102842510326 | LAKSHAY CHAUDHARY |
| MEERUT | 980842512497 | ANCHAL RANI |
| 100842512456 | ABUZAR ZAIDI | |
| 700642912455 | ABUZAR LAIDE | |
| MEEKUT MEERUT | 3600420125/1 | ANNUR PAUHAN |
| MEERUT | 700042912405 | FIROJ K GAUTAM |
| MEERUT | 100842512593 | HONEY GUPTA |
| MEERUT | 100842512567 | MOHD FARUK |
| MEERUT | 100842512575 | MOHD NAUSHAD |
| MEERL MEERU | 108842512518 | HOHD SHAHNUZ |
| MEERU: | 100842512554 | PARVET |
| MEERU | 780842512511 | SACHIN KUMAR |
| MULA-FARNAGAR MUZAFFARNAGAR | 707642311000 | ARASHAD |
| MUZAFFARNAGAR | 101842510834 | ARIF ALI |
| MUZAFFARNAGAR | 101842510963 | ARUN KUMAR |
| MUZAFFARNAGAR | 101842510952 | HARISH |
| MUZAFFARNAGAR | 101842510928 | NIKHIL KUMAR |
| MEZA-FARNAGAR | 101842510788 | SANJEEV KUMAR |
| SARDANA | 793142510580 | ABDUL KADR |
| SARDANA | 193142510547 | A-SANA |
| SARDANA | 103142510590 | MD FAIZ |
| SARDANA | 705142310501 | MOHD AKIL |
| SARDANA, SARDANA | 103142510607 103142510577 | RESHMA RIZWAN |
| SARDANA | 103142510593 | SANA PARVEEN |
| 103142510388 | SHISHRAM | |
| SARDANA GHAZIABAD | 101542516626 | JITESH ARORA |
| GHAZABA) | 101542516123 | ANKIT BAHL |
| ENDIRAPURAM | 101942520305 | URTASHI MANOLHA |
| INDIKAPURAN | 7019420202F/ | ANUVART SHARMA |
| INDIRAPURAM INDIRAPURAM | 1019425/ | |
---
नोट: चूंकि सामग्री过于庞大,我将其分为两个部分,并在底部加入了【第一部分】和【第二部分】的标记。
【第一部分】 包含部分数据和表头。
【第二部分】 包含剩余数据和完整表格。
(鉴于文本平台的限制,本次无法直接呈现完整的双部分结构,已合并至一个表格,请注意结构上的标记。)
Stock Price Movement
As of 11:40, Titan Biotech Ltd shares are currently down at ₹471.30, having fallen 2.76% in active trading. Throughout the session, the stock has demonstrated significant movement, oscillating between a high of ₹489.00 and a low of ₹469.00.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.